| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 43.118 | 45.355 | 57.134 | 60.253 | 37.624 | 40.321 | 50.113 | 80.481 | 92.587 |
| Total Income - EUR | - | 43.119 | 45.356 | 57.134 | 60.288 | 37.624 | 40.322 | 50.114 | 80.482 | 92.587 |
| Total Expenses - EUR | - | 24.224 | 37.031 | 43.857 | 39.780 | 27.215 | 28.267 | 37.700 | 57.353 | 67.056 |
| Gross Profit/Loss - EUR | - | 18.895 | 8.325 | 13.278 | 20.508 | 10.409 | 12.054 | 12.414 | 23.129 | 25.532 |
| Net Profit/Loss - EUR | - | 17.602 | 7.162 | 11.564 | 18.700 | 9.280 | 10.845 | 11.107 | 19.875 | 21.528 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Totalclin Max Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 120 | 2.308 | 2.265 | 2.221 | 2.179 | 2.131 | 2.137 | 2.131 | 2.119 |
| Current Assets | - | 20.370 | 22.662 | 34.086 | 53.106 | 59.970 | 70.722 | 80.992 | 103.282 | 65.744 |
| Inventories | - | 0 | 0 | 5 | 267 | 5 | 16 | 1.277 | 1.558 | 2.057 |
| Receivables | - | 0 | 0 | 0 | 3.840 | 332 | 6.162 | 9.242 | 88.233 | 60.363 |
| Cash | - | 20.370 | 22.662 | 34.081 | 48.999 | 59.632 | 64.544 | 70.473 | 13.490 | 3.324 |
| Shareholders Funds | - | 17.646 | 24.510 | 35.624 | 53.633 | 61.897 | 71.369 | 82.697 | 102.321 | 21.569 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.844 | 459 | 728 | 1.694 | 252 | 1.484 | 433 | 3.092 | 46.294 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Totalclin Max Srl